Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check4 days agoChange DetectedAdded a Hepatocellular carcinoma tag and a link to the Genetic and Rare Diseases Information Center; updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.4.2 added, and the government funding lapse notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check47 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with a link to opm.gov for updates, and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check54 days agoChange DetectedUI and footer metadata updates: added a 'Show glossary' label, corrected capitalization of 'Last Update Submitted that Met QC Criteria', and updated the footer to include 'No FEAR Act Data' and 'Revision: v3.4.0'.SummaryDifference0.2%

- Check68 days agoChange DetectedSoftware template revision updated from v3.3.3 to v3.3.4. No study content or user-facing layout changes are apparent.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.